Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.

Latta-Mahieu M, Elmer B, Bretteville A, Wang Y, Lopez-Grancha M, Goniot P, Moindrot N, Ferrari P, Blanc V, Schussler N, Brault E, Roudières V, Blanchard V, Yang ZY, Barneoud P, Bertrand P, Roucourt B, Carmans S, Bottelbergs A, Mertens L, Wintmolders C, Larsen P, Hersley C, McGathey T, Racke MM, Liu L, Lu J, O'Neill MJ, Riddell DR, Ebneth A, Nabel GJ, Pradier L.

Glia. 2018 Mar;66(3):492-504. doi: 10.1002/glia.23260. Epub 2017 Nov 14.

PMID:
29134678
2.

Proximity Ligation Assay: A Tool to Study Endogenous Interactions Between Tau and Its Neuronal Partners.

Bretteville A, Demiautte F, Chapuis J.

Methods Mol Biol. 2017;1523:297-305.

PMID:
27975258
3.

Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology.

Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B.

Mol Psychiatry. 2017 Jun;22(6):874-883. doi: 10.1038/mp.2016.59. Epub 2016 Apr 26.

4.

Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format.

Medda X, Mertens L, Versweyveld S, Diels A, Barnham L, Bretteville A, Buist A, Verheyen A, Royaux I, Ebneth A, Cabrera-Socorro A.

J Biomol Screen. 2016 Sep;21(8):804-15. doi: 10.1177/1087057116638029. Epub 2016 Mar 16.

PMID:
26984927
5.

Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain.

Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T, Delay C, Alves Dos Alves H, Flaig A, Davies P, Dourlen P, Dermaut B, Laporte J, Amouyel P, Lippens G, Chapuis J, Landrieu I, Lambert JC.

Acta Neuropathol Commun. 2015 Sep 23;3:58. doi: 10.1186/s40478-015-0237-8.

6.

Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.

Whittington RA, Virág L, Gratuze M, Petry FR, Noël A, Poitras I, Truchetti G, Marcouiller F, Papon MA, El Khoury N, Wong K, Bretteville A, Morin F, Planel E.

Neurobiol Aging. 2015 Aug;36(8):2414-28. doi: 10.1016/j.neurobiolaging.2015.05.002. Epub 2015 May 9.

7.

Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions.

Petry FR, Pelletier J, Bretteville A, Morin F, Calon F, Hébert SS, Whittington RA, Planel E.

PLoS One. 2014 May 2;9(5):e94251. doi: 10.1371/journal.pone.0094251. eCollection 2014.

8.

Insulin dysfunction and Tau pathology.

El Khoury NB, Gratuze M, Papon MA, Bretteville A, Planel E.

Front Cell Neurosci. 2014 Feb 11;8:22. doi: 10.3389/fncel.2014.00022. eCollection 2014. Review.

9.

Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation.

Whittington RA, Bretteville A, Virág L, Emala CW, Maurin TO, Marcouiller F, Julien C, Petry FR, El-Khoury NB, Morin F, Charron J, Planel E.

Sci Rep. 2013;3:1388. doi: 10.1038/srep01388.

10.

Anesthesia and tau pathology.

Whittington RA, Bretteville A, Dickler MF, Planel E.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:147-55. doi: 10.1016/j.pnpbp.2013.03.004. Epub 2013 Mar 25. Review.

11.

Deregulation of protein phosphatase 2A and hyperphosphorylation of τ protein following onset of diabetes in NOD mice.

Papon MA, El Khoury NB, Marcouiller F, Julien C, Morin F, Bretteville A, Petry FR, Gaudreau S, Amrani A, Mathews PM, Hébert SS, Planel E.

Diabetes. 2013 Feb;62(2):609-17. doi: 10.2337/db12-0187. Epub 2012 Sep 6.

12.

Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.

Ando K, Dourlen P, Sambo AV, Bretteville A, Bélarbi K, Vingtdeux V, Eddarkaoui S, Drobecq H, Ghestem A, Bégard S, Demey-Thomas E, Melnyk P, Smet C, Lippens G, Maurage CA, Caillet-Boudin ML, Verdier Y, Vinh J, Landrieu I, Galas MC, Blum D, Hamdane M, Sergeant N, Buée L.

Neurobiol Aging. 2013 Mar;34(3):757-69. doi: 10.1016/j.neurobiolaging.2012.08.004. Epub 2012 Aug 25.

PMID:
22926167
13.

Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylation.

Julien C, Marcouiller F, Bretteville A, El Khoury NB, Baillargeon J, Hébert SS, Planel E.

PLoS One. 2012;7(6):e40020. doi: 10.1371/journal.pone.0040020. Epub 2012 Jun 29.

14.

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors.

Bretteville A, Marcouiller F, Julien C, El Khoury NB, Petry FR, Poitras I, Mouginot D, Lévesque G, Hébert SS, Planel E.

Sci Rep. 2012;2:480. doi: 10.1038/srep00480. Epub 2012 Jun 29.

15.

Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

Julien C, Bretteville A, Planel E.

Methods Mol Biol. 2012;849:473-91. doi: 10.1007/978-1-61779-551-0_32. Review.

PMID:
22528110
16.

Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes.

Bretteville A, Ando K, Ghestem A, Loyens A, Bégard S, Beauvillain JC, Sergeant N, Hamdane M, Buée L.

PLoS One. 2009;4(3):e4843. doi: 10.1371/journal.pone.0004843. Epub 2009 Mar 17.

17.

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Planel E, Bretteville A, Liu L, Virag L, Du AL, Yu WH, Dickson DW, Whittington RA, Duff KE.

FASEB J. 2009 Aug;23(8):2595-604. doi: 10.1096/fj.08-122424. Epub 2009 Mar 11.

18.

Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.

Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, Kumar A, Bretteville A, Figueroa HY, Yu WH, Whittington RA, Davies P, Takashima A, Nixon RA, Duff KE.

J Neurosci. 2008 Nov 26;28(48):12798-807. doi: 10.1523/JNEUROSCI.4101-08.2008.

19.

Tau aggregates: toxic, inert, or protective species?

Bretteville A, Planel E.

J Alzheimers Dis. 2008 Aug;14(4):431-6. Review.

PMID:
18688094
20.

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.

Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, Wang L, Herman M, Figueroa H, Yu WH, Arancio O, Duff K.

Neurobiol Dis. 2008 Jul;31(1):46-57. doi: 10.1016/j.nbd.2008.03.005. Epub 2008 Apr 7.

PMID:
18504134
21.

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L.

Expert Rev Proteomics. 2008 Apr;5(2):207-24. doi: 10.1586/14789450.5.2.207. Review.

PMID:
18466052
22.

Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.

Schindowski K, Belarbi K, Bretteville A, Ando K, Buée L.

Genes Brain Behav. 2008 Feb;7 Suppl 1:92-100. doi: 10.1111/j.1601-183X.2007.00377.x.

23.

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.

Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, Yilmaz Z, Buée L, Brion JP.

Am J Pathol. 2007 Sep;171(3):976-92. Epub 2007 Aug 9.

24.
25.

Pin1 allows for differential Tau dephosphorylation in neuronal cells.

Hamdane M, Dourlen P, Bretteville A, Sambo AV, Ferreira S, Ando K, Kerdraon O, Bégard S, Geay L, Lippens G, Sergeant N, Delacourte A, Maurage CA, Galas MC, Buée L.

Mol Cell Neurosci. 2006 May-Jun;32(1-2):155-60. Epub 2006 May 11.

PMID:
16697218
26.

p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.

Hamdane M, Bretteville A, Sambo AV, Schindowski K, Bégard S, Delacourte A, Bertrand P, Buée L.

J Cell Sci. 2005 Mar 15;118(Pt 6):1291-8. Epub 2005 Mar 1.

27.

The Lower Hydrates of Soap.

Buerger MJ, Smith LB, de Bretteville A, Ryer FV.

Proc Natl Acad Sci U S A. 1942 Dec;28(12):526-9. No abstract available.

Supplemental Content

Loading ...
Support Center